Unique ID issued by UMIN | UMIN000053318 |
---|---|
Receipt number | R000060859 |
Scientific Title | A Multi-center Intervention Study on the Usefulness of Single Group Psychoeducational Session for Patients Using the "Guide for Pharmacological Therapy of Schizophrenia 2022" |
Date of disclosure of the study information | 2024/01/15 |
Last modified on | 2024/01/10 23:35:25 |
The usefulness of psychoeducation for patients using the Guide for Pharmacological Therapy of Schizophrenia 2022 (UKE-KOTSU) study
Psychoeducation using the Guide for Pharmacological Therapy of Schizophrenia (UKE-KOTSU) Study
A Multi-center Intervention Study on the Usefulness of Single Group Psychoeducational Session for Patients Using the "Guide for Pharmacological Therapy of Schizophrenia 2022"
Psychoeducation using the Guide for Pharmacological Therapy of Schizophrenia (UKE-KOTSU) Study
Japan |
schizophrenia
Psychiatry |
Others
NO
Group psychoeducation for schizophrenia patients will be conducted using the "Guide for Pharmacological Therapy of Schizophrenia 2022" to examine changes in knowledge of the illness and the effects on mid- to long-term medical adherance and their qulity of life.
Efficacy
Changes in Knowledge of Medication for Schizophrenia Before and After Psychoeducation
Changes in the level of practice of receiving treatment using the Guide and attitude toward medications before the implementation of psychoeducation and every 6 months up to 18 months thereafter. Changes in patients' Quality Of Life from before psychoeducation up to 5 years every 6 months thereafter.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
A 60-minute single group psychoeducational session using the "Guide for pharmacological therapy of Schizophrenia 2022"
18 | years-old | <= |
Not applicable |
Male and Female
- Patients who are judged by their attending psychiatrist to meet the diagnostic criteria for schizophrenia according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th edition).
- Persons who are judged by the attending psychiatrist to be eligible to participate in the study.
- Age 18 years or older at the time consent is obtained.
- Those who have given written consent to participate in the study.
- Persons with comorbid dementia
- Persons whose psychiatric symptoms are considered to be affected by substances or other medical conditions
- Other persons deemed unsuitable by the principal investigator or principal investigator-in-charge.
160
1st name | Kayo |
Middle name | |
Last name | Ichihashi |
University of Tokyo Hospital
Department of Neuropsychiatry
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-5800-9263
ichihashi-ymh@umin.ac.jp
1st name | Kayo |
Middle name | |
Last name | Ichihashi |
University of Tokyo Hospital
Department of Neuropsychiatry
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-5800-9263
ichihashi-ymh@umin.ac.jp
University of Tokyo
Japan Agency for Medical Research and Development; AMED
Japanese Governmental office
Research Ethics Committee of the Faculty of Medicine of the University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-5841-0818
ethics@m.u-tokyo.ac.jp
NO
2024 | Year | 01 | Month | 15 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 11 | Month | 15 | Day |
2023 | Year | 12 | Month | 29 | Day |
2024 | Year | 01 | Month | 15 | Day |
2031 | Year | 09 | Month | 30 | Day |
2024 | Year | 01 | Month | 10 | Day |
2024 | Year | 01 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060859